- Home
- ASND vs ALLE Comparison
ASND vs ALLE Comparison
Compare ASND & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | ALLE |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | Denmark | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 13.9B |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ASND | ALLE |
|---|---|---|
| Price | $228.00 | $141.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 8 |
| Target Price | ★ $279.50 | $171.13 |
| AVG Volume (30 Days) | 440.9K | ★ 723.8K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 7.44 |
| Revenue | N/A | N/A |
| Revenue This Year | $97.60 | $8.60 |
| Revenue Next Year | $43.64 | $4.28 |
| P/E Ratio | ★ N/A | $18.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $124.06 | $116.57 |
| 52 Week High | $248.60 | $183.11 |
Technical Indicators
Market Signals| Indicator | ASND | ALLE |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 32.64 |
| Support Level | $190.49 | $134.67 |
| Resistance Level | $233.88 | $167.42 |
| Average True Range (ATR) | 8.02 | 3.36 |
| MACD | 0.34 | 0.43 |
| Stochastic Oscillator | 66.05 | 18.44 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.